Bon Secours Liver Institute of Virginia

Richmond, Virginia 23226

0 studies enrolling now · 8 studies all time

What they study most

Biliary Cirrhosis, Primary, Decompensated Cirrhosis, HCV, Hepatitis C, Hepatocellular Cancer, Hepatocellular Carcinoma, Non-Alcoholic Steatohepatitis, Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Pruritus

Studies at this site

• A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• A Longitudinal Observational Study of the Natural History and Management of Patients With HCC — Running, not enrolling
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis — Completed
• Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis — Completed
• Direct Acting Antiviral-Post Authorization Safety Study — Completed
• Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects — Completed
• Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — Status unconfirmed